Aspire Biopharma Holdings, Inc. ASBP Q1 2025 Annual earnings
Reported May 14, 2025 · Before market open
Next report
Date not yet announcedVersus estimates
Diluted EPS
Ask the moment Aspire Biopharma Holdings, Inc. reports.
Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.
Connect your AI
Claude
Questions, answered.
- When did Aspire Biopharma Holdings, Inc. report Q1 2025 earnings?
- Aspire Biopharma Holdings, Inc. (ASBP) reported Q1 2025 earnings on May 14, 2025 before market open.
- What were Aspire Biopharma Holdings, Inc.'s Q1 2025 revenue and EPS?
- Aspire Biopharma Holdings, Inc. reported diluted EPS of $-0.42 for Q1 2025.
- How did Aspire Biopharma Holdings, Inc.'s Q1 2025 results compare year-over-year?
- Compared to the same quarter a year prior, diluted EPS declined 512.2% from $-0.07.
- Where can I find Aspire Biopharma Holdings, Inc.'s Q1 2025 SEC filings?
- You can read the 10-K periodic report (0001641172-25-002917) directly on SEC EDGAR. The filing index links above go to sec.gov.